adipose tissue-derived mesenchymal stem cell-derived exosomes (University of Utah/SymbioCellTech)

N/A

Report date: 2025/03/14 16:40:21

Base Information

Drug Nameadipose tissue-derived mesenchymal stem cell-derived exosomes (University of Utah/SymbioCellTech)
Drug Alias NameASC-derived exosome therapy (University of Utah/SymbioCellTech)
ClassificationBiologics > Exosomes > Stem cell-derived exosomesCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Utah
China Registration ClassN/A

Develop Information

Active CompaniesSymbioCellTech LLCThe University Of Utah
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A